113 related articles for article (PubMed ID: 28686044)
1. Anti-biofilm properties of a mupirocin spray formulation against Escherichia coli wound infections.
Bakkiyaraj D; Sritharadol R; Padmavathi AR; Nakpheng T; Srichana T
Biofouling; 2017 Aug; 33(7):591-600. PubMed ID: 28686044
[TBL] [Abstract][Full Text] [Related]
2. Development of a topical mupirocin spray for antibacterial and wound-healing applications.
Sritharadol R; Nakpheng T; Wan Sia Heng P; Srichana T
Drug Dev Ind Pharm; 2017 Oct; 43(10):1715-1728. PubMed ID: 28581830
[TBL] [Abstract][Full Text] [Related]
3. An open study of mupirocin in Libyan patients with skin infections.
El Ferghani N
J Int Med Res; 1995; 23(6):508-17. PubMed ID: 8746621
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of mupirocin calcium ointment in the treatment of experimental wound infections caused by methicillin-resistant strains of Staphylococcus aureus.
Beale AS; Gisby J; Sutherland R
J Chemother; 1989 Jul; 1(4 Suppl):397-8. PubMed ID: 16312457
[No Abstract] [Full Text] [Related]
5. Formulation development of cream with mupirocin and essential oils for eradication of biofilm mediated antimicrobial resistance.
Sundaramoorthy M; Karuppaiah A; Nithyanth M; Baberoselin R; Ramesh S; Geetha N; Veintramuthu S
Arch Microbiol; 2021 May; 203(4):1707-1715. PubMed ID: 33459816
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of a new cream formulation of mupirocin: comparison with oral and topical agents in experimental skin infections.
Gisby J; Bryant J
Antimicrob Agents Chemother; 2000 Feb; 44(2):255-60. PubMed ID: 10639346
[TBL] [Abstract][Full Text] [Related]
7. Opportunities for mupirocin calcium cream in the emergency department.
Williford PM
J Emerg Med; 1999; 17(1):213-20. PubMed ID: 9950412
[TBL] [Abstract][Full Text] [Related]
8. Pitted keratolysis: successful management with mupirocin 2% ointment monotherapy.
Greywal T; Cohen PR
Dermatol Online J; 2015 Aug; 21(8):. PubMed ID: 26437161
[TBL] [Abstract][Full Text] [Related]
9. TXA497 as a topical antibacterial agent: comparative antistaphylococcal, skin deposition, and skin permeation studies with mupirocin.
Dorrani M; Kaul M; Parhi A; LaVoie EJ; Pilch DS; Michniak-Kohn B
Int J Pharm; 2014 Dec; 476(1-2):199-204. PubMed ID: 25263100
[TBL] [Abstract][Full Text] [Related]
10. [Mupirocin resistance in methicillin-resistant Staphylococcus aureus strains isolated from wound infections].
Dolapçi I; Karahan ZC; Tekeli A; Koyuncu E; Azap A; Adaleti R
Mikrobiyol Bul; 2007 Jul; 41(3):435-40. PubMed ID: 17933255
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic efficacy of ozenoxacin in animal models of dermal infection with Staphylococcus aureus.
Tarragó C; Esquirol LP; Arañó A; Lachamp L; D'Aniello F; Zsolt I
Future Microbiol; 2018 May; 13():21-30. PubMed ID: 29745240
[TBL] [Abstract][Full Text] [Related]
12. Development of biofilm-targeted antimicrobial wound dressing for the treatment of chronic wound infections.
Ng SF; Leow HL
Drug Dev Ind Pharm; 2015; 41(11):1902-9. PubMed ID: 25758412
[TBL] [Abstract][Full Text] [Related]
13. Decrease in Staphylococcus aureus surgical-site infection rates after orthopaedic surgery after intranasal mupirocin ointment.
Coskun D; Aytac J
J Hosp Infect; 2004 Sep; 58(1):90-1. PubMed ID: 15350723
[No Abstract] [Full Text] [Related]
14. Mechanistic studies of the antibiofilm activity and synergy with antibiotics of isosorbide mononitrate.
Hasan S; Albayaty YNS; Thierry B; Prestidge CA; Thomas N
Eur J Pharm Sci; 2018 Mar; 115():50-56. PubMed ID: 29305985
[TBL] [Abstract][Full Text] [Related]
15. Hydrogels Containing Antibiofilm and Antimicrobial Agents Beneficial for Biofilm-Associated Wound Infection: Formulation Characterizations and In vitro Study.
Anjum A; Sim CH; Ng SF
AAPS PharmSciTech; 2018 Apr; 19(3):1219-1230. PubMed ID: 29280044
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of topical 2% mupirocin ointment for treatment of tympanostomy tube otorrhea caused by community-acquired methicillin resistant Staphylococcus aureus.
Yankey H; Isaacson G
Int J Pediatr Otorhinolaryngol; 2018 Jun; 109():36-39. PubMed ID: 29728181
[TBL] [Abstract][Full Text] [Related]
17. In vitro antibacterial effects of topical local anesthetics.
Sedef Gocmen J; Buyukkocak U; Caglayan O; Aksoy A
J Dermatolog Treat; 2008; 19(6):351-3. PubMed ID: 18608709
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial potency of single and combined mupirocin and monoterpenes, thymol, menthol and 1,8-cineole against Staphylococcus aureus planktonic and biofilm growth.
Kifer D; Mužinić V; Klarić MŠ
J Antibiot (Tokyo); 2016 Sep; 69(9):689-96. PubMed ID: 26883392
[TBL] [Abstract][Full Text] [Related]
19. [The effects of mupirocin on burned wound with Staphylococcus aureus infection].
Deng S; Sang J; Cao L
Zhonghua Zheng Xing Shao Shang Wai Ke Za Zhi; 1995 Jan; 11(1):45-8. PubMed ID: 7600433
[TBL] [Abstract][Full Text] [Related]
20. Chitosan and α-cellulose-based mupirocin topical film-forming spray: Optimization, in vitro characterization, antimicrobial studies and wound healing activity.
Patil N; Wairkar S
Int J Biol Macromol; 2024 Jan; 254(Pt 1):127622. PubMed ID: 37890752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
